Celltrion
068270.KS
#709
Rank
ยฃ22.44 B
Marketcap
ยฃ109.21
Share price
3.11%
Change (1 day)
-0.31%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ1.96 Billion

According to Celltrion 's latest financial reports the company's total liabilities are ยฃ1.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ1.06 B4.88%
2021-12-31ยฃ1.01 B-5.99%
2020-12-31ยฃ1.07 B65.26%
2019-12-31ยฃ0.65 B1.57%
2018-12-31ยฃ0.64 B4.47%
2017-12-31ยฃ0.61 B10.84%
2016-12-31ยฃ0.55 B2.71%
2015-12-31ยฃ0.53 B-5.74%
2014-12-31ยฃ0.57 B11.5%
2013-12-31ยฃ0.51 B25.96%
2012-12-31ยฃ0.40 B44.42%
2011-12-31ยฃ0.28 B30.54%
2010-12-31ยฃ0.21 B47%
2009-12-31ยฃ0.14 B-4.37%
2008-12-31ยฃ0.15 B710.36%
2007-12-31ยฃ18.94 M